10 results match your criteria: "Mater Children's Hospitals[Affiliation]"
Perit Dial Int
December 2015
Australasian Kidney Trials Network, University of Queensland, Brisbane, Australia Department of Nephrology, Princess Alexandra Hospital, Brisbane, Australia
Unlabelled: ♦
Background: The HONEYPOT study recently reported that daily exit-site application of antibacterial honey was not superior to nasal mupirocin prophylaxis for preventing overall peritoneal dialysis (PD)-related infection. This paper reports a secondary outcome analysis of the HONEYPOT study with respect to exit-site infection (ESI) and peritonitis microbiology, infectious hospitalization and technique failure. ♦
Methods: A total of 371 PD patients were randomized to daily exit-site application of antibacterial honey plus usual exit-site care (N = 186) or intranasal mupirocin prophylaxis (in nasal Staphylococcus aureus carriers only) plus usual exit-site care (control, N = 185).
Nephrology (Carlton)
February 2015
Child & Adolescent Renal Service, Royal Children's and Mater Children's Hospitals, University of Queensland, Brisbane, Queensland, Australia.
Lancet Infect Dis
January 2014
Australasian Kidney Trials Network, University of Queensland, Brisbane, QLD, Australia; Department of Nephrology, Princess Alexandra Hospital, Brisbane, QLD, Australia.
Background: There is a paucity of evidence to guide the best strategy for prevention of peritoneal-dialysis-related infections. Antibacterial honey has shown promise as a novel, cheap, effective, topical prophylactic agent without inducing microbial resistance. We therefore assessed whether daily application of honey at the exit site would increase the time to peritoneal-dialysis-related infections compared with standard exit-site care plus intranasal mupirocin prophylaxis for nasal carriers of Staphylococcus aureus.
View Article and Find Full Text PDFNephrology (Carlton)
June 2013
Child & Adolescent Renal Service, Royal Children's and Mater Children's Hospitals, Brisbane, Queensland, Australia.
J Paediatr Child Health
December 2011
Queensland Children's Cancer Centre, Royal Children's and Mater Children's Hospitals, Australia.
Background: Vincristine is a key component of many childhood cancer treatment regimens. Pharmacodynamic parameters such as clinical efficacy and toxicity may be influenced by polymorphisms of CYP3A.
Aim: The aim of this study was to document CYP3A5 genotype, vincristine pharmacokinetics (PK) and neurotoxicity profile for 50 children with cancer and determine whether, in a population of Australian children, the CYP3A5 genotype influenced the pharmacodynamics of vincristine as reflected by peripheral neurotoxicity.
Pediatr Neurosurg
March 2012
Department of Neurosurgery, Royal Children's and Mater Children's Hospitals, Brisbane, QLD, Australia.
Background: The management of hydrocephalus secondary to intraventricular haemorrhage in neonates can be controversial. Temporary diversion of cerebrospinal fluid (CSF) is often required due to the low birth weight and high risks of shunting in these patients. Ventriculosubgaleal (VSG) CSF diversion is an effective way of achieving this goal whilst minimising the risks of complications.
View Article and Find Full Text PDFPediatr Nephrol
September 2010
Queensland Child and Adolescent Renal Service, Royal Children's Hospital and Mater Children's Hospitals, Herston Road, 4029 Herston, Brisbane, Queensland, Australia.
Peritonitis is a common complication and major cause of morbidity in children on peritoneal dialysis. In this retrospective longitudinal study, we analysed data retrieved from the Australian and New Zealand Dialysis and Transplant Registry (ANZDATA) on 167 patients aged less than 18 years of age who were treated with peritoneal dialysis during the period from October 2003 to December 2007. During this period there were 100 episodes of peritonitis in 57 patients (0.
View Article and Find Full Text PDFNephrology (Carlton)
February 2007
Queensland Child and Adolescent Renal Service, Royal Children's and Mater Children's Hospitals, Brisbane QLD, Australia.
Pediatr Nephrol
November 2006
Queensland Child and Adolescent Renal Service, Royal Children's Hospital and Mater Children's Hospitals, Brisbane, Queensland, Australia.
Idiopathic infantile hypercalcaemia (IIH) is a rare disorder of unknown etiology that presents with hypercalcaemia in a child's first year of life. There is only a limited number of published reports of the natural history of this condition, and the long-term prognosis is largely unknown. The presentation, treatment and long-term follow-up of 11 children with IIH treated at our institution since 1993 are described.
View Article and Find Full Text PDFIntensive Crit Care Nurs
December 2003
Intensive Care Unit, Mater Children's Hospitals, Brisbane, P.O. Box 214, Bulimba 4171, Qld, Australia.
Background: With no UK collective information system, a need existed to establish an integrated information system for public and private sector hospitals providing paediatric and infant critical care services. A lack of information in the past made it difficult for those procuring, providing and monitoring services to make informed, evidence-based decisions using reliable integrated data.
Objectives: To develop and implement a collective multi-purpose information system for paediatric and infant critical care that was easily adaptable to any UK infant or paediatric critical care setting.